From chemical building blocks, scientists have created synthetic cells that have most of the hallmarks of life.

Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...

Direct Indexing (DI) isn’t a one-and-done tax play. While most see it as a transition tool, its power also lies in its enduring investment value. By continuously harvesting tax losses and taking ...

Index providers are bending their rules. Do they have a choice? Nasdaq tweaked its rules to allow Elon Musk’s newly public SpaceX SPCX into its flagship Nasdaq-100 Index after 15 days of trading. FTSE ...